Search Results (23)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Clinical Trials, Phase I as Topic | Concept |
Why?
|
| Clinical Trials, Phase II as Topic | Concept |
Why?
|
| Clinical Trials, Phase III as Topic | Concept |
Why?
|
| Clinical Trials, Phase IV as Topic | Concept |
Why?
|
| Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls. | Academic Article |
Why?
|
| Ginn, Kevin | Person |
Why?
|
| Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model. | Academic Article |
Why?
|
| Gamis, Alan | Person |
Why?
|
| Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531. | Academic Article |
Why?
|
| Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group. | Academic Article |
Why?
|
| Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. | Academic Article |
Why?
|
| Warady, Bradley | Person |
Why?
|
| Guest, Erin | Person |
Why?
|
| Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis. | Academic Article |
Why?
|
| Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group. | Academic Article |
Why?
|